- freely available
- re-usable
Int. J. Mol. Sci. 2012, 13(10), 13621-13666; doi:10.3390/ijms131013621
Review
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
1
Department of Biomedical Sciences and Cancer Biology Center, Texas Tech University Health Sciences Center School of Pharmacy, 1300 S. Coulter, Amarillo, TX 79106, USA
2
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
3
Cancer Preventive Material Development Research Center, College of Oriental Medicine, Kyunghee University, Seoul 130-701, Korea
* Authors to whom correspondence should be addressed.
Received: 5 September 2012; in revised form: 8 October 2012 / Accepted: 11 October 2012 / Published: 22 October 2012
(This article belongs to the Special Issue Advances in Molecular Oncology)
Abstract: Tanshinones are a class of abietane diterpene compound isolated from Salvia miltiorrhiza (Danshen or Tanshen in Chinese), a well-known herb in Traditional Chinese Medicine (TCM). Since they were first identified in the 1930s, more than 40 lipophilic tanshinones and structurally related compounds have been isolated from Danshen. In recent decades, numerous studies have been conducted to investigate the isolation, identification, synthesis and pharmacology of tanshinones. In addition to the well-studied cardiovascular activities, tanshinones have been investigated more recently for their anti-cancer activities in vitro and in vivo. In this review, we update the herbal and alternative sources of tanshinones, and the pharmacokinetics of selected tanshinones. We discuss anti-cancer properties and identify critical issues for future research. Whereas previous studies have suggested anti-cancer potential of tanshinones affecting multiple cellular processes and molecular targets in cell culture models, data from in vivo potency assessment experiments in preclinical models vary greatly due to lack of uniformity of solvent vehicles and routes of administration. Chemical modifications and novel formulations had been made to address the poor oral bioavailability of tanshinones. So far, human clinical trials have been far from ideal in their design and execution for the purpose of supporting an anti-cancer indication of tanshinones.
Keywords: tanshinones; sources; pharmacokinetic; anti-cancer
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Zhang, Y.; Jiang, P.; Ye, M.; Kim, S.-H.; Jiang, C.; Lü, J. Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities. Int. J. Mol. Sci. 2012, 13, 13621-13666.
AMA StyleZhang Y, Jiang P, Ye M, Kim S-H, Jiang C, Lü J. Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities. International Journal of Molecular Sciences. 2012; 13(10):13621-13666.
Chicago/Turabian StyleZhang, Yong; Jiang, Peixin; Ye, Min; Kim, Sung-Hoon; Jiang, Cheng; Lü, Junxuan. 2012. "Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities." Int. J. Mol. Sci. 13, no. 10: 13621-13666.
Int. J. Mol. Sci.
EISSN 1422-0067
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert
